Insulin increases NADH/NAD+ redox state, which stimulates guanylate cyclase in vascular smooth muscle

Andrew M Kahn1, Julius C Allen, Sui Zhang

  • 1Department of Medicine. The University of Texas Health Science Center, Houston 77225, USA.

Abstract

Insights

Insulin boosts cyclic GMP (cGMP) in vascular smooth muscle cells (VSMCs) by altering cellular redox state, not by directly activating guanylate cyclase. This pathway may enhance nitric oxide availability.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Vascular Physiology

Background:

  • Insulin inhibits vascular smooth muscle cell (VSMC) contraction and migration.
  • This inhibition is mediated by increased cyclic guanosine monophosphate (cGMP) production in VSMCs expressing inducible nitric oxide synthase (iNOS).
  • The precise mechanism by which insulin stimulates guanylate cyclase activity remained unclear.

Purpose of the Study:

  • To elucidate the mechanism by which insulin stimulates guanylate cyclase activity in canine VSMCs.
  • To investigate the role of cellular redox state and metabolic pathways in insulin-mediated cGMP production.

Main Methods:

  • Primary canine VSMCs were cultured and treated with insulin.
  • Measurements included lactate-to-pyruvate ratio (LPR) to assess redox state (NADH/NAD+), cGMP production, iNOS activity, and cell contraction.
  • Specific inhibitors like NG-monomethyl-L-arginine (L-NMMA) and metabolic modulators (pyruvate, oxaloacetate) were used.

Main Results:

  • Insulin significantly increased cGMP production and the LPR in VSMCs with iNOS, indicating a shift in the NADH/NAD+ redox state.
  • Insulin's stimulation of cGMP was dependent on iNOS activity and the increased LPR, as blocking these pathways with L-NMMA or metabolic intermediates inhibited the effect.
  • Insulin did not directly stimulate guanylate cyclase activity in cells lacking iNOS, suggesting an indirect mechanism involving iNOS-derived nitric oxide.

Conclusions:

  • Insulin enhances cGMP production in VSMCs expressing iNOS by increasing the cellular NADH/NAD+ redox state.
  • This metabolic alteration likely increases the availability of nitric oxide (NO) from iNOS, leading to cGMP production.
  • The findings suggest an indirect mechanism where insulin modulates cellular metabolism to influence NO-cGMP signaling.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...